Prevalence of moderate penicillin resistant invasive Neisseria meningitidis infection in Scotland, 1994-9

Epidemiol Infect. 2002 Apr;128(2):149-56. doi: 10.1017/s0950268801006549.


We examined the serological characteristics of 774 invasive meningococcal isolates collected through an active laboratory-based surveillance system in Scotland from 1994 to 1999. Of these, 72-73% of isolates were tested for susceptibility to several antimicrobial agents. Meningococci with high-level resistance to sulphadiazine had a prevalence of 10% and incidence of 0.22 per 100,000 population. High-level resistance to penicillin and other antibiotics was not detected. The prevalence of moderate penicillin resistant meningococci was 8.3%. There was no increase in moderate penicillin resistant meningococcal isolates during the study period, but there were temporal and geographic variations. The estimated incidence of moderate penicillin resistant meningococci was 0.15 per 100,000 population. High and low incidence of moderate penicillin resistant meningococci appeared to correlate with the number of doses of penicillin prescribed in some geographic locations. The majority of moderate penicillin resistant isolates belonged to serogroups B (52.2%) and C (39.2%). However, the prevalence of moderate penicillin resistance in serogroup W135 was substantially higher (51.7%) than serogroups B (7.8%) and C (7.6%). Serogroup W135 accounted for a higher proportion of moderate penicillin resistance (8.7%) than disease (1%). There was no predominant penicillin resistant serotype/subtype within any serogroup. Constant surveillance is necessary to monitor the emergence and spread of resistance and to guide appropriate public health interventions in preventing drug resistant meningococci.

MeSH terms

  • Humans
  • Meningococcal Infections / drug therapy*
  • Meningococcal Infections / epidemiology
  • Neisseria meningitidis / classification
  • Neisseria meningitidis / drug effects*
  • Neisseria meningitidis / pathogenicity
  • Penicillin Resistance*
  • Prevalence
  • Public Health
  • Scotland / epidemiology
  • Serotyping